This company has been marked as potentially delisted and may not be actively trading. Surface Oncology (SURF) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock SURF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Method AI raises $20m to advance robotic surgery assistance technologyAugust 23, 2025 | msn.comHepatocellular Carcinoma Pipeline Appears Robust With 90+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsightMay 7, 2025 | theglobeandmail.comInternational conference at the Thangam Cancer Center - Experts delivering edging Tech in Medical field at NamakkalJanuary 25, 2025 | msn.comCan estrogen cream combat skin aging signs? Here’s what dermatologists say.November 14, 2024 | washingtonpost.com‘Tremendous potential’: Cell therapy shows promise in treating deadly brain cancer in new trialNovember 14, 2024 | msn.comCAR-T therapy offers hope against an incurable brain tumor: patient shows no sign of disease after four yearsNovember 14, 2024 | msn.comTreatment offers promise for 'terrible, terrible' brain cancer in young peopleNovember 14, 2024 | msn.comQ3 2024 Heron Therapeutics Inc Earnings CallNovember 13, 2024 | finance.yahoo.comAura Biosciences Reports Third Quarter 2024 Financial Results and Business HighlightsNovember 12, 2024 | markets.businessinsider.comVANCE trial marks milestone in t cell therapy for solid tumorsNovember 12, 2024 | msn.comNeoGenomics, Inc. (NASDAQ:NEO) Q3 2024 Earnings Call TranscriptNovember 8, 2024 | msn.comEpiBiologics to Present Data Demonstrating Disease-Selective Extracellular Protein Degradation and Platform Breadth at Upcoming Scientific MeetingsNovember 5, 2024 | finance.yahoo.comOncoinvent Announces Publication of 18-Month Safety and Efficacy Data from the Phase 1/2a Study of Radspherin in Colorectal CancerNovember 3, 2024 | finanznachrichten.dePancreatic Ductal Adenocarcinoma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and BarriersNovember 2, 2024 | theglobeandmail.comFueling The Fight: How Ovarian Tumors Drain T Cell EnergyOctober 31, 2024 | forbes.comRyvu Therapeutics to Collaborate with nCage Therapeutics on the Development of a Next-Generation ADC PlatformOctober 29, 2024 | finance.yahoo.comBreast cancer in Africa: Myths that need to be debunkedOctober 29, 2024 | msn.comSpanish Researchers Discover the Secret of HIV Controllers in Their Defenses: "The Response to the Virus is Stronger"October 25, 2024 | msn.comEQS-News: Heidelberg Pharma to Participate in Leading Scientific and Financial Conferences in November 2024October 24, 2024 | markets.businessinsider.comThe ‘Junk’ Genome May Actually Unlock The Next Cancer TreatmentOctober 24, 2024 | forbes.comHow early puberty may contribute to the rise of breast cancer among younger womenOctober 19, 2024 | msn.comSmall-cap biotech Jaguar Health’s stock jumps 7% as it launches treatment for oral mucositis in cancer patientsOctober 16, 2024 | msn.comHeart Failure and Cancer: New Insights into a Reciprocal Relationship and Emerging Treatment ApproachesOctober 16, 2024 | finance.yahoo.comNYU Langone researchers address the challenges of heart failure in cancer patientsOctober 16, 2024 | msn.comWhich Pharma Stock Is the Better Bargain Buy: Pfizer or Eli Lilly?October 14, 2024 | msn.comJenna Fischer, ‘The Office’ Star, Reveals Breast Cancer DiagnosisOctober 10, 2024 | nytimes.comArda Therapeutics Secures $43M Series A Financing to Advance Targeted Cell Depletion TherapiesOctober 9, 2024 | finance.yahoo.com‘The Office’ star Jenna Fischer reveals triple-positive breast cancer diagnosisOctober 9, 2024 | msn.comA Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patientsOctober 9, 2024 | msn.comA Navy Yard biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients.October 8, 2024 | msn.comPromising cell therapy offers hope for relapsed or refractory T-cell leukemiaOctober 7, 2024 | msn.comNew cell therapy offers effective treatment for patients with T-cell acute lymphoblastic leukemiaOctober 7, 2024 | msn.comIs aloe vera the key to perfect skin? Here’s what the science says.October 4, 2024 | msn.comPROMISING CELL THERAPY OFFERS HOPE FOR RELAPSED OR REFRACTORY T-CELL LEUKAEMIAOctober 4, 2024 | finance.yahoo.comUmoja Biopharma Announces Poster Presentations at the 39th Annual Meeting of the Society for Immunotherapy of CancerOctober 4, 2024 | markets.businessinsider.comJMP Securities Downgrades Gritstone bio (GRTS)October 2, 2024 | msn.comResults from a Phase I clinical trial of a dendritic cell targeting prophylactic HIV vaccine published in the Journal eClinical MedicineOctober 2, 2024 | markets.businessinsider.comScientists unveil a 3D photoacoustic scanner that speeds up vascular imaging for real-time clinical useOctober 2, 2024 | msn.comLuxa Biotechnology LLC Appoints Keith E. Dionne, Ph.D., as Chief Executive OfficerOctober 1, 2024 | finance.yahoo.comDistinguished Oncologist, Professor Daniel Von Hoff joins the Scientific/Clinical Advisory Board of EnGeneIC Cancer TherapeuticsOctober 1, 2024 | markets.businessinsider.comCancer Therapy: AOP Health Investigates a New Approach Targeting Cancer Stem CellsOctober 1, 2024 | finance.yahoo.comPipeline Moves: Pfizer scores in Phase II cancer cachexia trialOctober 1, 2024 | msn.comInnovative CAR-T cells effectively target glioblastoma with reduced toxicitySeptember 27, 2024 | msn.comNavigating the complexities of healthcare cybersecuritySeptember 27, 2024 | msn.comScientists develop CAR-T cells to target glioblastoma while sparing healthy tissueSeptember 26, 2024 | msn.comFulgent Genetics: An NCAV Pick With Profit And Growth PotentialSeptember 25, 2024 | seekingalpha.comEnGeneIC Selects Global CDMO BioCina to Advance Their Ground-Breaking Cancer TreatmentSeptember 24, 2024 | finance.yahoo.comESPN's Dick Vitale finishes final radiation treatment for cancerous lymph node in his neckSeptember 24, 2024 | msn.comSabrina Carpenter Reclaims Australian Chart DoubleSeptember 23, 2024 | yahoo.comThis experimental lung cancer drug outperforms blockbuster medicine Keytruda. But there’s a catchSeptember 21, 2024 | msn.com Get Surface Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for SURF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SURF Media Mentions By Week SURF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SURF News Sentiment▼0.000.94▲Average Medical News Sentiment SURF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SURF Articles This Week▼01▲SURF Articles Average Week Get the Latest News and Ratings for SURF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Surface Oncology and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Hyperion DeFi News PHAXIAM Therapeutics News Adial Pharmaceuticals News 60 Degrees Pharmaceuticals News Alpha Tau Medical News BriaCell Therapeutics News enGene News Fortress Biotech News GeoVax Labs News Jasper Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SURF) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredThe Orphaned Well Crisis Hidden Across AmericaAcross the U.S., millions of abandoned oil and gas wells are leaking methane into the air — a costly and dange...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surface Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surface Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SURF Stock Alerts